Botulinum Toxin Studied as Therapy for Scleroderma-Associated Raynaud’s Syndrome

Author: Alisa Woods
Date Published: January-2015
Source: Scleroderma News

Botulinum toxin has been very popular for reducing wrinkles and more recently for treating painful conditions. The toxin may soon have a new use for another medical condition. Johns Hopkins University researchers are studying whether botulinum toxin can provide relief to people suffering from scleroderma-associated Raynaud’s Syndrome. Scleroderma is a chronic autoimmune disease characterized by hardening connective tissue. Almost all people with scleroderma have Raynaud’s symptoms. In Raynaud’s syndrome, areas of the body such as the fingers and toes feel numb and cold in response to cold or stress. This occurs because small arteries narrow, restricting blood circulation.